Inhibition of the cyclooxygenase/lipoxygenase pathways to improve interferon alpha efficacy in chronic hepatitis C: don't lose the tract!
Andreone
P
P
Gramenzi
A
A
Cursaro
C
C
Bernardi
M
M
D000998:Antiviral Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000494:pharmacology* / Q000627:therapeutic use; D016859:Lipoxygenase Inhibitors / Q000494:pharmacology*; D015203:Reproducibility of Results; D018401:Sample Size; D019562:Viral Load
D000998:Antiviral Agents; D016861:Cyclooxygenase Inhibitors; D016898:Interferon-alpha; D016859:Lipoxygenase Inhibitors